Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 077513
Company: ACTAVIS ELIZABETH

• Other Important Information from FDA

Products on ANDA 077513

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RAMIPRIL	RAMIPRIL	1.25MG	CAPSULE;ORAL	Discontinued	None	No	No
RAMIPRIL	RAMIPRIL	2.5MG	CAPSULE;ORAL	Discontinued	None	No	No
RAMIPRIL	RAMIPRIL	5MG	CAPSULE;ORAL	Discontinued	None	No	No
RAMIPRIL	RAMIPRIL	10MG	CAPSULE;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 077513

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/18/2008	ORIG-1	Approval				Label is not available on this site.